1. Health Canada. About Health Canada (2012). http://www.hc-sc.gc.ca/ahc-asc/index-eng.php . Accessed 2 Nov 2012.
2. Health Canada. Description of current risk communication documents for marketed health products for human use – guidance document (2011). http://www.hc-sc.gc.ca/dhp-mps/pubs/medeff/_guide/2008-risk-risques_comm_guid-dir/index-eng.php . Accessed 15 Jul 2013.
3. Health Canada. Health Canada’s response to the Carlin Jury recommendations aimed at the department or directly relevant to its mandate (2011). http://www.hc-sc.gc.ca/ahc-asc/pubs/hpfb-dgpsa/inquest-enquete_carlin-eng.php . Accessed 1 Feb 2013.
4. Office of the Auditor General. 2011 June status report of the Auditor General. http://www.oag-bvg.gc.ca/internet/English/parl_oag_201106_06_e_35374.html . Accessed 11 Feb 2013.
5. Bahri P, Harrison-Woolrych M. Focusing on risk communication about medicines. Drug Saf. 2012;35(11):971–5.